These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22673852)

  • 21. Topical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression.
    Gürdal C; Genç I; Saraç O; Gönül I; Takmaz T; Can I
    Curr Eye Res; 2010 Sep; 35(9):771-7. PubMed ID: 20795858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of ocular surface damage and dry eye status in chronic hepatitis C at different stages of hepatic fibrosis.
    Gumus K; Yurci A; Mirza E; Arda H; Oner A; Topaktas D; Karakucuk S
    Cornea; 2009 Oct; 28(9):997-1002. PubMed ID: 19724213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a role for neurotrophin treatment of the ocular surface following laser in situ keratomileusis (LASIK)?
    Pepose JS; Johnson EM
    Am J Ophthalmol; 2005 Jun; 139(6):1090-4. PubMed ID: 15953442
    [No Abstract]   [Full Text] [Related]  

  • 25. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
    Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
    Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review study.
    Shoari A; Kanavi MR; Rasaee MJ
    Exp Eye Res; 2021 Apr; 205():108523. PubMed ID: 33662353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limitations of an ocular surface inflammatory biomarker in impression cytology specimens.
    Yafawi R; Ko M; Sace FP; John-Baptiste A
    Cutan Ocul Toxicol; 2013 Mar; 32(1):46-53. PubMed ID: 22867431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiinflammatory therapy for dry eye.
    Pflugfelder SC
    Am J Ophthalmol; 2004 Feb; 137(2):337-42. PubMed ID: 14962426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving awareness, identification, and management of meibomian gland dysfunction.
    Foulks GN; Nichols KK; Bron AJ; Holland EJ; McDonald MB; Nelson JD
    Ophthalmology; 2012 Oct; 119(10 Suppl):S1-12. PubMed ID: 23034341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gelatinase expression in ocular surface disorders.
    Sakimoto T; Shoji J; Kanno H; Sawa M
    Jpn J Ophthalmol; 2004; 48(1):17-22. PubMed ID: 14767645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic dry eye and regression after laser in situ keratomileusis for myopia.
    Albietz JM; Lenton LM; McLennan SG
    J Cataract Refract Surg; 2004 Mar; 30(3):675-84. PubMed ID: 15050267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.
    Sobrin L; Liu Z; Monroy DC; Solomon A; Selzer MG; Lokeshwar BL; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1703-9. PubMed ID: 10845589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tear function and ocular surface findings in premature and term babies.
    Dogru M; Karakaya H; Baykara M; Ozmen A; Koksal N; Goto E; Matsumoto Y; Kojima T; Shimazaki J; Tsubota K
    Ophthalmology; 2004 May; 111(5):901-5. PubMed ID: 15121366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and management.
    Berdy GJ; Hedqvist B
    Acta Ophthalmol Scand Suppl; 2000; (230):32-7. PubMed ID: 11057347
    [No Abstract]   [Full Text] [Related]  

  • 35. A practical treatment algorithm for managing ocular surface and tear disorders.
    Tseng SC
    Cornea; 2011 Oct; 30 Suppl 1():S8-S14. PubMed ID: 21912234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New perspectives in ocular surface disorders. An integrated approach for diagnosis and management.
    Sangwan VS; Tseng SC
    Indian J Ophthalmol; 2001 Sep; 49(3):153-68. PubMed ID: 15887723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of complications and recommendations for management in dissatisfied patients seeking a consultation after refractive surgery.
    Jabbur NS; Sakatani K; O'Brien TP
    J Cataract Refract Surg; 2004 Sep; 30(9):1867-74. PubMed ID: 15342048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dry eye syndrom--multispecialistic disease. Part two: diagnostic procedure and treatment].
    Nowak M; Marek B; Kajdaniuk D; Siemińska L; Kos-Kudła B; Nowak K; Głogowska-Szelag J
    Wiad Lek; 2011; 64(1):49-55. PubMed ID: 21812364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases.
    Versura P; Profazio V; Campos EC
    Curr Eye Res; 2010 Jul; 35(7):553-64. PubMed ID: 20597641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances in the diagnosis and therapy for diseases of the ocular surface: dry eye and ocular allergies].
    Messmer EM; Benitez del Castello J; Lambiase A; Doan S
    Klin Monbl Augenheilkd; 2006 Aug; 223(8):643-9. PubMed ID: 16927218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.